Published November 07. 2013 4:00AM
Amarin Corp. plc plans a live webcast at 4:30 p.m. today to discuss third-quarter financial results.
The Irish-based biotech company, which has its research headquarters in Groton, is expected to post widening losses in the quarter as it continued efforts to prove the efficacy of its key drug, Vascepa, in clinical trials. Amarin's stock price has fallen about 70 percent in recent weeks, following a U.S. advisory panel's recommendation that Vascepa not be granted an immediate approval for use in expanded populations.
To attend the webcast, dial (877) 407-8033 or go online to www.investorcalendar.com. Replays of the call will be at www.amarincorp.com.